Mesa Laboratories, Inc.Mesa Laboratories, Inc.Mesa Laboratories, Inc.

Mesa Laboratories, Inc.

No trades
See on Supercharts
Market capitalization
‪545.55 M‬USD
‪930.00 K‬USD
‪219.08 M‬USD
‪5.21 M‬
Beta (1Y)
0.63

About Mesa Laboratories, Inc.

CEO
Gary M. Owens
Headquarters
Lakewood
Employees (FY)
698
Founded
1982
ISIN
US59064R1095
FIGI
BBG000BP3PW7
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Instrument segment designs, manufactures, and markets control instruments and disposable products used in the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, and environmental air sampling industries. The Biopharmaceutical Development segment develops and sells automated systems for protein analysis and peptide synthesis solutions. The Continuous Monitoring segment includes development of systems used to monitor various environmental parameters. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MLAB is 99.62 USD — it has decreased by 1.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mesa Laboratories, Inc. stocks are traded under the ticker MLAB.
Mesa Laboratories, Inc. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
MLAB stock is 3.80% volatile and has beta coefficient of 0.63. Check out the list of the most volatile stocks — is Mesa Laboratories, Inc. there?
One year price forecast for Mesa Laboratories, Inc. has a max estimate of 130.00 USD and a min estimate of 130.00 USD.
MLAB earnings for the last quarter are 1.91 USD whereas the estimation was 1.79 USD which accounts for 6.90% surprise. Estimated earnings for the next quarter are 1.79 USD. See more details about Mesa Laboratories, Inc. earnings.
Mesa Laboratories, Inc. revenue for the last quarter amounts to ‪53.17 M‬ USD despite the estimated figure of ‪55.43 M‬ USD. In the next quarter revenue is expected to reach ‪54.90 M‬ USD.
Yes, you can track Mesa Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
MLAB stock has fallen by 4.74% compared to the previous week, the month change is a 2.11% fall, over the last year Mesa Laboratories, Inc. has showed a 39.10% decrease.
MLAB net income for the last quarter is ‪2.12 M‬ USD, while the quarter before that showed ‪−1.23 M‬ USD of net income which accounts for 272.03% change. Track more Mesa Laboratories, Inc. financial stats to get the full picture.
Today Mesa Laboratories, Inc. has the market capitalization of ‪545.55 M‬, it has increased by 6.78% over the last week.
Yes, MLAB dividends are paid quarterly. The last dividend per share was 0.16 USD. As of today, Dividend Yield (TTM)% is 0.63%. Tracking Mesa Laboratories, Inc. dividends might help you take more informed decisions.
Mesa Laboratories, Inc. dividend yield was 0.37% in 2022, and payout ratio reached 368.88%. The year before the numbers were 0.25% and 182.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MLAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mesa Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
MLAB reached its all-time high on Dec 28, 2021 with the price of 333.42 USD, and its all-time low was 0.25 USD and was reached on Oct 7, 1987.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 698.00 employees. See our rating of the largest employees — is Mesa Laboratories, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mesa Laboratories, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mesa Laboratories, Inc. stock shows the sell signal. See more of Mesa Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Mesa Laboratories, Inc. future price: according to them, MLAB price has a max estimate of 130.00 USD and a min estimate of 130.00 USD. Read a more detailed Mesa Laboratories, Inc. forecast: see what analysts think of Mesa Laboratories, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mesa Laboratories, Inc. EBITDA is ‪34.83 M‬ USD, and current EBITDA margin is 16.64%. See more stats in Mesa Laboratories, Inc. financial statements.